Alkem Laboratories Executes Block Deal, Sells 1.5% Stake for ₹930 Crore at ₹5,200 Per Share

Alkem Laboratories Shares in Focus After Rs 930 Crore Block Deal

Shares of Alkem Laboratories Ltd are likely to remain in focus on Tuesday following a large block deal worth approximately Rs 930 crore. According to exchange data, the transaction involved the sale of nearly 17.88 lakh shares at Rs 5,200 per share, indicating a discount of about 2.2 percent to Alkem Laboratories' previous closing price of Rs 5,318.

The block deal follows reports that the Samprada and Nanhamati Family Trust was looking to sell up to a 1.5 percent stake in the pharmaceutical company. The trust was represented by authorised individual beneficiaries and sellers Sandeep Singh and Jayanti Sinha, according to a term sheet accessed by CNBC-TV18. The term sheet had indicated a floor price of Rs 5,200 per share and specified a 90-day lock-up period on any further sale of shares by the sellers.

The transaction size works out to roughly Rs 930 crore, which is the result of selling approximately 1.5 percent of the company's equity. This sale comes after Alkem Laboratories shares had declined 3.3 percent in Monday's session to close at Rs 5,318. Despite the recent weakness, the stock has gained about 4.4 percent over the past one year, outperforming the Nifty 50, which has declined around 5.4 percent during the same period.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Alkem Laboratories is an Indian pharmaceutical company with a presence across domestic formulations, international markets, and active pharmaceutical ingredients. The company commands a market capitalisation of more than Rs 63,500 crore.